5 big analyst AI moves: Apple lifted to Buy, AI chip bets reassessed
Investing.com -- Swedish medical technology company Bonesupport reported third-quarter 2025 net sales of SEK294.1 million, representing a 34% increase in constant currency compared to the same period last year.
The quarterly sales figure was in line with Stockholm forecasts of SEK296 million, though it fell 3.2% below consensus estimates. The company posted an adjusted EBIT margin of approximately 27%, matching consensus expectations of 27% and slightly below Stockholm forecasts of 27.3%.
Despite the solid growth, Bonesupport shares fell 5% following the announcement.
North American sales of CERAMENT G continued to drive the company’s top-line growth, accounting for 62% of overall sales. The product gained market share across both osteomyelitis and trauma applications.
The company is scheduled to hold a conference call at 10am CET on Thursday to discuss the results. Key topics expected to be addressed include the upcoming US launch of C-BVF in Spine Fusion targeted for December, plans to introduce C-G/V into the US Spine market, and potential strategic views under the leadership of new CEO Torbjörn Sköld.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.